Picard Medical Securities Fraud Lawsuits
Analysis based on 21 articles · First reported Feb 12, 2026 · Last updated Apr 12, 2026
The class action lawsuits against Picard Medical, Inc. by Rosen Law Firm and Levi & Korsinsky are expected to negatively impact Picard Medical, Inc.'s stock price and investor confidence due to allegations of fraudulent stock promotion and misleading statements. This event highlights the risks associated with social media-driven stock promotions and potential insider trading, prompting increased scrutiny from investors and regulatory bodies.
Picard Medical, Inc. is facing multiple class action securities lawsuits filed by Rosen Law Firm and Levi & Korsinsky. The lawsuits allege that Picard Medical, Inc. engaged in a fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals between September 2, 2025, and October 31, 2025. It is also claimed that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign. The lawsuits assert that Picard Medical, Inc.'s public statements and risk disclosures omitted any mention of these false rumors and artificial trading activity, leading to materially misleading statements about the company's business, operations, and prospects. Investors who suffered losses during this period are encouraged to join the class actions, with an important lead plaintiff deadline of April 13, 2026.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard